MeMed CEO Eran Eden, PhD, discusses the MeMed BV test and how it can help make the distinction between the types of infections, aid in patient management, and reduce antimicrobial resistance.
Eran Eden, PhD
Advertisement
Eden is MeMed's co-founder and CEO.
Articles by Eran Eden, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Cases of Cyclosporiasis Continue to Rise Across 31 States With Michigan Reporting Highest Numbers
2
Cyclosporiasis: When to Seek Medical Care, Duration of Illness, and Preventive Measures
3
New Single-Step Test Nearly Doubles Early Lyme Disease Detection
4
Antiviral Being Used in Current Ebola Outbreak Advances Through Dual Development Strategy
5